Oxygenta Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE102E01018
  • NSEID:
  • BSEID: 524636
INR
48.29
-2.09 (-4.15%)
BSENSE

Jul 17, 03:30 PM

BSE+NSE Vol: 6.94 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "48.29",
    "chg": -2.09,
    "chgp": "-4.15%",
    "dir": -1,
    "prev_price": "50.38",
    "mcapval": "189.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE102E01018",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "09:19 AM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": "6.94 k",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-4104973",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OxygentaPharmac_mojoScore_4104973.png",
        "date": "2026-07-16 10:10:29",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-4089434",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/OxygentaPharmac_mojoScore_4089434.png",
        "date": "2026-07-05 10:10:19",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 September 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 05 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-4070269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OxygentaPharmac_mojoScore_4070269.png",
        "date": "2026-06-24 10:10:45",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-4048898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OxygentaPharmac_mojoScore_4048898.png",
        "date": "2026-06-12 10:10:24",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Five Consecutive Losses Push Oxygenta Pharmaceutical Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-falls-to-52-week-low-of-rs43-4046820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OxygentaPharmac_priceRelatedfactors_4046820.png",
        "date": "2026-06-11 15:36:50",
        "description": ""
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-4024355",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OxygentaPharmac_mojoScore_4024355.png",
        "date": "2026-05-31 10:10:18",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Oxygenta Pharmaceutical Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-oxygenta-pharmaceutical-ltd-4001749",
        "imagepath": "",
        "date": "2026-05-20 23:19:01",
        "description": "The next results date for Oxygenta Pharmaceutical Ltd is scheduled for 23 May 2026...."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3998872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OxygentaPharmac_mojoScore_3998872.png",
        "date": "2026-05-19 10:10:22",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3981512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OxygentaPharmac_mojoScore_3981512.png",
        "date": "2026-05-08 10:10:22",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 236,
    "sid": "798135",
    "stock_news_url": "https://www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Jul-2026",
      "details": "Compliance as per Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Jun-2026",
      "details": "Closure of trading window for the period ending 30.06.2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "26-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Regulation 24A of SEBI (LODR) Regulations 2018.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

14-Jul-2026 | Source : BSE

Compliance as per Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026.

Closure of Trading Window

24-Jun-2026 | Source : BSE

Closure of trading window for the period ending 30.06.2026.

Compliances-Reg.24(A)-Annual Secretarial Compliance

26-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Regulation 24A of SEBI (LODR) Regulations 2018.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available